Clinical trials
Active, not recruiting Phase 2 trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
300 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 7 |
| 2016 | 6 |
| 2017 | 7 |
| 2018 | 22 |
| 2019 | 24 |
| 2020 | 19 |
| 2021 | 23 |
| 2022 | 35 |
| 2023 | 42 |
| 2024 | 64 |
| 2025 | 42 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 300 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 16 |
| AstraZeneca | 14 |
| Merck Sharp & Dohme LLC | 13 |
| Hoffmann-La Roche | 12 |
| Gilead Sciences | 8 |
| GlaxoSmithKline | 8 |
| Janssen Research & Development, LLC | 8 |
| Sanofi | 8 |
| University College, London | 6 |
| AbbVie | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 15 |
| Carcinoma, Non-Small-Cell Lung | 13 |
| Colitis, Ulcerative | 9 |
| Melanoma | 9 |
| Colorectal Neoplasms | 8 |
| Head and Neck Neoplasms | 8 |
| Lymphoma, Mantle-Cell | 7 |
| Ovarian Neoplasms | 7 |
| Recurrence | 7 |
| Lymphoma, Large B-Cell, Diffuse | 6 |
Trials
Showing 1 to 25 of 300. Each trial links to its page on Pharma Observatory.
200 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.